缬草 Valeriana officinalis

忍冬科 缬草属

味苦，性凉。
清热解毒，消肿敛脓。

四川省藏药材标准·2014年版

本种相关内容撰写时，引用的参考文献如下：
[1] 中国科学院中国植物志编辑委员会. 中国植物志•第七十三卷•第一分册[M]. 北京:科学出版社, 1986.
[2] 中国药材公司. 中国中药资源志要[M]. 北京:科学出版社, 1994.
[3] 罗达尚. 中华藏本草[M]. 北京:民族出版社, 1997.
[4] 青海省生物研究所,同仁县隆务诊疗所. 青藏高原药物图鉴•第一册[M]. 西宁:青海人民出版社, 1972.
[5] 四川省药品监督管理局. 四川省藏药材标准:2014年版[M]. 成都:四川科学技术出版社, 2014.
[6] 李荣贵. 尔玛思柏:中国羌药谱[M]. 北京:中国农业出版社, 2013.
[7] 卫生部生物制品鉴定所. 中国民族药志.二卷[M]. 北京:人民卫生出版社, 1990.
[8] UZEL K, TURKLER C, MAMMADOV R, et al. Valeriana officinalis is Effective on Stress-Induced Infertility, Delayed Maternity, and Intrauterine Growth Restriction of the Fetus in Female Rats [J]. Latin American Journal of Pharmacy, 2021, 40(11):2821-2828.
[9] Anima M S , Pierrine M G, Clara S, et al. Constituents of Passiflora incarnata, but Not of Valeriana officinalis, Interact with the Organic Anion Transporting Polypeptides (OATP)2B1 and OATP1A2 [J]. Planta Medica, 2022, 88(2):152-162. DOI:10.1055/a-1305-3936
[10] Liu X X, Duan X Y, Fan H, et al. 8-hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 Channel Blocker [J]. Journal of Ethnopharmacology, 2021, 276:114168. DOI:10.1016/j.jep.2021.114168
[11] Wu G Q, Zhang Z L, Fan H, et al. A New Iridoid Glycoside Isolated from Valeriana officinalis L. [J]. Records of Natural Products, 2022, 16(4):393-397. DOI:10.25135/rnp.283.2107-2145
[12] Ulrich-Merzenich G, Shcherbakova A, Kolb C. Modulation of the Neurothrophic Activity by Ballota nigra L. Crataegus oxycantha L., Passiflora incarnata L. and Valeriana officinalis L. and their Combination in vitro [J]. Planta Medica, 2021, 87(15):1315. DOI:10.1055/s-0041-1736988
[13] Kamil J, Maria F, Barbara T, et al. The Toxicological Risk Assessment of Lead and Cadmium in Valeriana officinalis L., radix (Valerian root) as Herbal Medicinal Product for the Relief of Mild Nervous Tension and Sleep Disorders Available in Polish Pharmacies [J]. Biological Trace Element Research, 2022, 200:904-909. DOI:10.1007/s12011-021-02691-5
[14] Kamil J, Maria F, Barbara T, et al. Ni and Cr impurities profile in Valeriana officinalis L., radix-based herbal medicinal product available in polish pharmacies due to ICH Q3D guideline [J]. Regulatory Toxicology and Pharmacology, 2021, 123:104945. DOI:10.1016/j.yrtph.2021.104945
[15] Kamil J, Maria F, Barbara T, et al. The Toxicological Risk Assessment of Cu, Mn, and Zn as Essential Elemental Impurities in Herbal Medicinal Products with Valerian Root (Valeriana officinalis L., radix) Available in Polish Pharmacies [J]. Biological Trace Element Research, 2022, 200:1949-1955. DOI:10.1007/s12011-021-02779-y
[16] Mohammad B, Ali N, Ahmad T, et al. Identification of key genes associated with secondary metabolites biosynthesis by system network analysis in Valeriana officinalis [J]. Journal of Plant Research, 2021, 134:625-639. DOI:10.1007/s10265-021-01277-5
[17] Seyyedeh A M, Neda D, Rasoul R, et al. Phosphate concentrations and methionine application affect quantitative and qualitative traits of valerian (Valeriana officinalis L.) under hydroponic conditions [J]. Industrial Crops and Products, 2021, 171:113821. DOI:10.1016/j.indcrop.2021.113821